Medical News

RSS

Unique pain program helps surgical patients wean off opioids safely and effectively

A unique pain program is helping complex surgical patients wean off opioids safely and effectively, while offering alternative ways to cope with their pain and improve how they function.

20 Aug 2018

New class of insect repellents to fight against mosquito-borne diseases

Nearly 700 million people suffer from mosquito-borne diseases - such as malaria, West Nile, Zika and dengue fever - each year, resulting in more than 1 million deaths. Increasingly, many species of mosquitoes have become resistant to the popular pyrethroid-based insecticides.

20 Aug 2018

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.

20 Aug 2018

RDMD raises $3 million in seed funding to accelerate rare disease research, drug development

RDMD, a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced that it has raised $3 million in seed financing.

20 Aug 2018

NYU Langone's Perlmutter Cancer Center expands Blood and Marrow Transplant Program

To further advance the study and treatment of blood cancers, Perlmutter Cancer Center at NYU Langone Health has significantly expanded its Blood and Marrow Transplant Program.

20 Aug 2018

Chagas disease causes chronic heart disease and has spread outside of Latin America

Chagas disease, caused by infection with a parasite called Trypanosoma cruzi (T cruzi), causes chronic heart disease in about one third of those infected.

20 Aug 2018

Illicit drug use is higher during celebratory events, may be worse than previously thought

America's drug problem may be even worse than officials realize. And illicit drugs are consumed at a higher rate during celebratory events. Those are just two of the conclusions scientists have drawn from recent studies of drug residues in sewage.

20 Aug 2018

New drug shows potential to prevent painful side effect of therapy

About 50,000 people in the U.S. are diagnosed annually with head, neck, nasal and oral cancers. Most are treated with radiation, and of those, 70-80 percent develop a painful and debilitating side effect called severe oral mucositis.

20 Aug 2018

E-cigarettes can damage DNA and increase the risk of cancer, say researchers

The chemicals present in e-cigarettes can alter DNA in oral cells and increase the risk of cancer, according a new study.

20 Aug 2018

Strawberries could mitigate colonic inflammation

Inflammatory bowel disease is a set of painful conditions that can cause severe diarrhea and fatigue. Treatments can include medications and surgery. But now researchers report that a simple dietary intervention could mitigate colonic inflammation and improve gut health.

20 Aug 2018

Elevated LDL cholesterol levels linked to higher risk of CVD death in young, healthy people

Young, healthy people may still face a lifetime risk of premature death from cardiovascular disease if they cannot keep their cholesterol levels in check, according to new observational research in the American Heart Association's journal Circulation.

20 Aug 2018

The man who sold America on vitamin D — and profited in the process

Dr. Michael Holick's enthusiasm for vitamin D can be fairly described as extreme.

20 Aug 2018

BOOST-3 clinical trial aims to improve outcomes for severe TBI patients

An estimated 2.5 million Americans sustain a traumatic brain injury, or TBI, each year, according to the Centers for Disease Control and Prevention. Severe TBI contributes to 30 percent of all injury-related deaths, and many who survive are left permanently disabled.

20 Aug 2018

New research center aims to improve health outcomes for people with physical disabilities

Nationally, 1 in 5 adults lives with a disability. But knowing what it's like for those 53 million people to age - and how their unique needs may change over time - isn't always clear to the professionals that provide care.

20 Aug 2018

Babies dependent on opioids need touch, not tech

Dr. Jodi Jackson has worked for years to address infant mortality in Kansas. Often, that means she treats newborns in a high-tech neonatal intensive care unit with sophisticated equipment whirring and beeping. And that is exactly the wrong place for an infant like Lili.

20 Aug 2018

GBCA creates model for developing scientist-advocate collaborations in cancer research

At Georgetown Lombardi Comprehensive Cancer Center, a group of breast cancer advocates say they've created a model for developing productive, successful, and sustainable collaborations between advocates and scientists in cancer research. They describe their efforts in an article published online August 17 in the journal Cancer Research.

20 Aug 2018

Thrombospondin-1 contributes to development of aortic aneurysm in mice and humans, study finds

Researchers centered at the University of Tsukuba and Kansai Medical University in Japan reveal matricellular protein Thrombospondin-1 (Thbs1) contributes to the development of aortic aneurysm in mice and humans.

20 Aug 2018

Brain tumors trap immune cells needed to fight cancer in the bone marrow, finds research

Certain brain cancers are associated with low numbers of immune system T-cells circulating in the peripheral blood. Low T-cell numbers can be a side-effect of cancer treatment. But it now appears that there is more to the story of these missing T-cells.

20 Aug 2018

New integrated gene logic-chips could have great value in medical care

Gene expression is a fundamental of life, where each cell switches on and off specific genes. Thus, an autonomous device that could control the on-off switching would have great value in medical care.

20 Aug 2018

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour BioMed today announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. to develop and commercialize A167, an anti-PD-L1 antibody in Phase 2 clinical development, worldwide outside of the Greater China region.

20 Aug 2018

Medical News

Unique pain program helps surgical patients wean off opioids safely and effectively

New class of insect repellents to fight against mosquito-borne diseases

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

RDMD raises $3 million in seed funding to accelerate rare disease research, drug development

NYU Langone's Perlmutter Cancer Center expands Blood and Marrow Transplant Program

Chagas disease causes chronic heart disease and has spread outside of Latin America

Illicit drug use is higher during celebratory events, may be worse than previously thought

New drug shows potential to prevent painful side effect of therapy

E-cigarettes can damage DNA and increase the risk of cancer, say researchers

Strawberries could mitigate colonic inflammation

Elevated LDL cholesterol levels linked to higher risk of CVD death in young, healthy people

The man who sold America on vitamin D — and profited in the process

BOOST-3 clinical trial aims to improve outcomes for severe TBI patients

New research center aims to improve health outcomes for people with physical disabilities

Babies dependent on opioids need touch, not tech

GBCA creates model for developing scientist-advocate collaborations in cancer research

Thrombospondin-1 contributes to development of aortic aneurysm in mice and humans, study finds

Brain tumors trap immune cells needed to fight cancer in the bone marrow, finds research

New integrated gene logic-chips could have great value in medical care

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News